Oral, direct Factor Xa inhibition with BAY 59-7939 for the...

Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement

B. I. ERIKSSON, L. BORRIS, O. E. DAHL, S. HAAS, M. V. HUISMAN, A. K. KAKKAR, F. MISSELWITZ, P. KÄLEBO, FOR THE ODIXA-HIP STUDY INVESTIGATORS
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
4
Year:
2006
Language:
english
Pages:
8
DOI:
10.1111/j.1538-7836.2005.01657.x
File:
PDF, 182 KB
english, 2006
Conversion to is in progress
Conversion to is failed